• Potential Parkinson’s Vaccine, Affitope PD01A, Safe and Possibly Effective in Long-term, Phase 1 Trial Series Finds
  • How 2 Sets Nerve Cells Interact to Control Movement Seen by Scientists Using New Tool
  • Affected Cell Type May Explain Differences in Parkinson’s-related Diseases, Study Suggests
  • Parkinson’s Researchers Unravel How Toxic Alfa-synuclein Affects Memory Nerve Cells
  • Rest Brings a New Perspective when Living with Parkinson’s
  • Enzyme Tied to Inflammation and Progression in Parkinson’s May Hold Key to Treatment, Study Says
  • Alnylam’s RNAi Therapy for Parkinson’s Disease Fares Well in Rat Model
  • Eli Lily Recruiting for Phase 2 Trial to Test LY3154207 for Parkinson’s Dementia
  • Charles River Laboratories, Michael J. Fox Foundation Extend Research Partnership
  • Finding Fulfillment in My Life
  • Dance-movement Therapy May Help Parkinson’s, Other Motor Diseases, Study Finds
  • MJFF Partners with Verily to Use Data Collection Watch in PPMI Study to Advance Parkinson’s Research